Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-02-02 @ 7:16 PM
Study NCT ID:
NCT00306566
Status:
COMPLETED
Last Update Posted:
2007-09-20
First Post:
2006-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Sponsor:
Cytos Biotechnology AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CYT004-MelQbG10 02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None